A failed trial at the American Heart Association leads to pointed fingers at game-changing research on Vascepa, and counter claims of "manufactured controversy."
January 25, 2021
The approval comes following a study on the efficacy of the migraine device.
January 25, 2021
Eric Whitaker, M.D., credits influences in high school and medical school with his success. Now he wants to turn his new Medicare Advantage plan, Zing Health, into a training ground for Black and Latino health insurance executives — and has his sights set on unicorn status.
January 24, 2021
Last year a lull in provider mergers and acquisitions was followed by an uptick. Experts say the disruptive effect of COVID-19 may mean plenty of deals this year.
January 23, 2021
Centralized technology that connects payers, providers and patients are needed to optimize telemedicine reimbursement, argues J.P. Morgan's Kerry Jessani.
January 22, 2021
The approval come following the results of a phase 3 trial.
January 21, 2021
Seniors still need additional information about Medicare Advantage and Star Ratings.
January 21, 2021
Although virtual visits as a whole have dropped off since their peak last spring, visits for behavioral health issues are still going strong, a reflection, in part, of the toll the COVID-19 pandemic has taken on the mental health of Americans.
January 20, 2021
Riding high because of the COVID-19 surge, telemedicine companies are going public and making expensive deals.
January 20, 2021
Bolstering the ACA and addressing healthcare inequities perhaps through Medicaid waivers may top the agenda. Experts see a continuation of support of ACOs and growth in enrollment in Medicare Advantage plans.
January 19, 2021
Nearly 80% of Americans believe the COVID-19 vaccines will help combat the pandemic, but 71% are concerned about vaccine side effects. Experts say some side effects are not only normal, but are working.